Skip to main content
. 2022 Apr 28;13(3):e00386-22. doi: 10.1128/mbio.00386-22

FIG 7.

FIG 7

Antigenic profile of mature DENV. (A) FRNT50 of DV1-WT and DV1-prM-D89K against 1C19, EDE1-C10 (C10), and 1M7. (B) FRNT50 of DV4-WT and DV4-prM-E89N against D4-126, D4-131, C10, and 1M7. (C) FRNT50 of DV2-WT and DV2-V1 against 1C19, EDE2-B7 (B7), C10, and 1M7. (D) FRNT50 of vaccine sera and traveler serum against DV4 and DV4-prM-E89N.